Hugel
Hugel秀杰
Hugel is South Korea's largest aesthetic medicine company, acquired in 2021 by a consortium led by CBC Group alongside South Korea's GS Group and Mubadala Investment Company . The deal, completed in a three-month sprint after Bain Capital signaled its exit, valued a 46.9% stake at roughly KRW 1.7 trillion (about RMB 9.43 billion) . For CBC Group founder Fu Wei, the Hugel buyout marked a step-up in ambition — his first cross-border pharmaceutical asset carve-out and a signature deal in a push from minority stakes toward control-oriented buyouts .
AI-generated — may contain errors, please verify.
HugelCompany
Hugel秀杰
渲染中…
Mentioned in 3 articles
Coverage
C-Bridge Capital Closes First Close of Over RMB 7 Billion Buyout Fund, Fu Wei's "Minority" Path
Over the past decade, CBC Group has risen from obscurity to manage 65 billion yuan in assets.
Fu Wei, who spent ten years doing control buyouts, said they are the blue-collar workers of the investment industry.
Go with the flow.
